MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » UPDATE: IntelligentMDx is ahead of schedule in developing its new Swine Flu test

UPDATE: IntelligentMDx is ahead of schedule in developing its new Swine Flu test

By

IntelligentMDx announced that it’s developed an assay solution for influenza that can distinguish seasonal strains from the H1N1 variant, better known as the Swine Flu.

The company said the assay will be available during the autumn flu season and was designed to comply with Food & Drug Administration and other regulatory guidelines.

IntelligentMDx spokeswoman Elizabeth Holland wrote in an email that the test can also detect a patient’s potential resistance or susceptibility to anti-viral medications.

The company is pursuing FDA approval and a CE Mark from the European Union, Holland added, writing that the company is ahead of schedule for getting the test to market.

“We realize the importance of the assay … in light of the heightened concern with the coming flu season and are doing everything within our capacity to pull the timeline in even further,” she wrote.

Intelligent Medical Devices raised $3 million in June from a pair of unidentified investors, taking its total investment nut to $22 million since its 2004* inception.

The company is working on so-called “intelligent” diagnostic kits for rapid tests of infectious diseases. The devices make copies of genetic material from a small number of cells or fluid samples, simultaneously testing them for chemical markers specific to different diseases.

The devices also rely on mathematical algorithms to predict test failure and to simulate outside factors such as genetic mutations or contamination that could affect results. CEO Alice Jacobs and two other Boston-area researchers received a U.S. patent in June 2005 for a prototype of the devices now being readied for production.

The company recently completed renovations at its Cambridge facility, roughly doubling its size to about 18,000 square feet and adding new Biosafety Level 2 (BL2) laboratory space. BL2 labs allow for work on infectious agents, with numerous safeguards built into their designs to keep disease-carrying materials from escaping the workspace as well as preventing outside contamination.

*Correction, 8/20/2009: IntelligentMDx launched in 2004, not 2000 as originally reported. Return to the corrected sentence.

In case you missed it

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply